Overview
WUXAY market data
Price History
No market bars yet for WUXAY. This page will populate once the next provider sweep lands.
Valuation & Profitability
- P/E (TTM)
- 18.45 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- $6.61 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.54 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- 150.2% Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- — Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $86.39 – $135.17 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · source Twelve Data /statistics · market cap $371.3K · P/B 3.36 · P/S 8.17.
Company News
Oligonucleotide CDMO Market to Reach USD 9.87 Billion by 2031 as RNA-Targeted Drug Pipelines ExpandGlobenewswire Inc · Jul 15, 2026, 11:15 AM
Global Clinical Trials Market to Reach $176.32 Billion by 2030 as AI and Decentralized Research Accelerate GrowthGlobenewswire Inc · Jul 15, 2026, 11:15 AM
Complex Small Molecules Are Changing Drug R&DGlobenewswire Inc · Jun 26, 2026, 11:15 AM
Global Cell and Gene Therapy CDMO Market Anticipating Remarkable Growth at a CAGR of ~24% by 2034 | DelveInsightGlobenewswire Inc · Jun 18, 2026, 5:15 PM
Is WuXi AppTec's Buyback Campaign Working Amid Mounting US Pressure?Benzinga · Jun 11, 2026, 2:30 PM
Novel Gastric Drug Hopes Fuel Strong Hong Kong Debut For Biotech FirmBenzinga · May 28, 2026, 2:15 PM
Protein Synthesis Research Market to Reach $42.8 Billion by 2031, Driven by Surging CGT InvestmentGlobenewswire Inc · May 18, 2026, 7:15 PM
Global Plasmid DNA Manufacturing Market Anticipates Impressive Growth Trajectory at a CAGR of ~18% by 2034 | DelveInsightGlobenewswire Inc · May 4, 2026, 5:10 PM